← Open Payments lookup

NATHAN VALENTINE: Open Payments

NPI 1154707552 · ABERDEEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$983 in 54 payments from 12 companies in 2025. Trend: 2023 $986 · 2024 $967 · 2025 $983

Food & beverage: $983
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$178
Amgen Inc.13$173
GlaxoSmithKline, LLC.7$153
PFIZER INC.9$143
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$91
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Phathom Pharmaceuticals, Inc.3$45
Novo Nordisk Inc2$42
Viatris Specialty LLC2$40
Abbott Laboratories1$20

Products named: TRELEGY ELLIPTA, OTEZLA, AIRSUPRA, XIFAXAN, PAXLOVID, JARDIANCE, BREZTRI, VOQUEZNA.

Industry payments across WA — which companies pay providers there.